The US Food and Drug Administration has approved a 4-week dosing schedule for a commonly used cancer therapy. READ MORE

News

The US Food and Drug Administration has approved a 4-week dosing schedule for a commonly used cancer therapy.

READ MORE

The US Food and Drug Administration has granted approval to a therapy in combination with an aromatase inhibitor for the treatment of a specific type of advanced breast cancer.

READ MORE

The FDA has approved the first treatment for a type of localized prostate cancer, using a novel endpoint to support the approval.

READ MORE

The FDA has approved a hormone-based chemotherapy in combination with prednisone for metastatic high-risk castration-sensitive prostate cancer.

READ MORE